Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients
Launched by HOSPICES CIVILS DE LYON · May 21, 2024
Trial Information
Current as of March 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a confirmed diagnosis of Wilson's Disease (Leipzig score ˃4).
- • Age ≥ 6 years and ≤70 years.
- • Patient able to perform 24h urine.
- • Current treatment with D-Pencillamine, Trientine or Zinc.
- • Non-opposition of patient and/or legal representatives for minor patients.
- Exclusion Criteria:
- • Patients who had a change in treatment within the last 6 months before the inclusion
- • Patients who have undergone liver transplantation
- • Patients with known chronic renal failure (GFR \< 30 ml/min)
- • Patients on long-term diuretic or corticosteroid therapy
- • Persons deprived of liberty by a judicial or administrative decision
- • Patient under judicial protection, unable to express consent
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bron, Rhone, France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
